Biomedical Engineering Reference
In-Depth Information
Paruchuri S (2010) Intraorganizational networks, interorganizational networks, and the impact of
central inventors: a longitudinal study of pharmaceutical fi rms. Organ Sci 21(1):63-81
Pavitt K, Robson M, Townsend J (1989) Technological accumulation, diversifi cation and organiza-
tion in UK companies, 1945-1983. Manage Sci 35(1):81-99
Phelps CC (2010) A longitudinal study of the infl uence of alliance network structure and composi-
tion on fi rm exploratory innovation. Acad Manage J 53(4):890-913
Pisano GP (2002) Discovering the future: R&D strategy at Merck. Harvard Business School, Case
Study 601-086
Powell WW, Koput KW, Smith-Doerr L (1996) Interorganizational collaboration and the locus of
innovation: networks of learning in biotechnology. Adm Sci Q 41:116-145
Rao RS, Chandy RK, Prabhu JC (2008) The fruits of legitimacy: why some new ventures gain
more from innovation than others. J Market 72(4):58-75
Rappa MA, Debackere K (1995) An analysis of entry and persistence among scientists in an
emerging fi eld of science: the case of neural networks. R&D Manage 25(3):323-341
Reagans RE, Zuckerman EW (2008) Why knowledge does not equal power: the network redun-
dancy trade-off. Ind Corp Change 17(5):903-944
Rothaermel FT (2001) Incumbent's advantage through exploiting complementary assets via inter-
fi rm cooperation. Strateg Manage J 22(Special Issue):687-699
Rowley T, Behrens D, Krackhardt D (2000) Redundant governance structures: an analysis of struc-
tural and relational embeddedness in the steel and semiconductor industries. Strateg Manage J
21(Special Issue 3):369-386
Sarkar MB, Aulakh PS, Madhok A (2009) Process capabilities and value generation in alliance
portfolios. Organ Sci 20(3):583-600
Sharpe P, Keelin T (1998) How SmithKline Beecham makes better resource-allocation decisions.
Harv Bus Rev 76(2):45-52
Simonet D (2002) Licensing agreements in the pharmaceutical industry. Int J Med Market
2(4):329-341
Soni PK, Lilien GL, Wilson DT (1993) Industrial innovation and fi rm performance: a re-
conceptualization and exploratory structural equation analysis. Int J Res Market 10:365-380
Stern I, Henderson AD (2004) Within-business diversifi cation in technology-intensive industries.
Strateg Manage J 25(5):487-505
Suzuki J, Kodama F (2004) Technological diversity of persistent innovators in Japan—two case
studies of large Japanese fi rms. Res Policy 33:531-549
Uzzi B (1997) Social structure and competition in interfi rm networks: the paradox of embedded-
ness. Adm Sci Q 42:35-67
Varadarajan PR (1986) Product diversity and fi rm performance: an empirical investigation.
J Market 50(2):43-57
Vassolo RS, Anand J, Folta TB (2004) Non-additivity in portfolios of exploration activities: a real
options-based analysis of equity alliances in biotechnology. Strateg Manage J 25(11):1045-1061
Veugelers R, Cassiman B (1999) Make and buy in innovation strategies: evidence from Belgian
manufacturing fi rms. Res Policy 28:63-80
Wassmer U (2010) Alliance portfolios: a review and research agenda. J Manage 36(1):141-171
Wuyts S, Dutta S (2008) Licensing exchange: insights from the biopharmaceutical industry. Int J
Res Market 25(4):273
Wuyts S, Dutta S (2012) Benefi ting from alliance portfolio diversity: the role of past internal
knowledge creation strategy. J Manage forthcoming (fi rst online March 23, 2012)
Wuyts S, Dutta S, Stremersch S (2004a) Portfolios of interfi rm agreements in technology-intensive
markets: consequences for innovation and profi tability. J Market 68(2):88-100
Wuyts S, Stremersch S, Van den Bulte C, Franses P-H (2004b) Vertical marketing systems for
complex products: a triadic perspective. J Market Res 41(4):479
Wuyts S, Colombo M, Dutta S, Nooteboom B (2005) Empirical tests of optimal cognitive distance.
J Econ Behav Organ 58(2):277-302
Search WWH ::
Custom Search